TRNX
$2.09
Taronis Technologies
$.33
18.75%
TRNX
Earnings Whisper ®
N/A
3rd Quarter September 2019
Consensus:  $0.00
Revenue:  $6.46 Mil
Monday
Nov 18
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when TRNX reports earnings?
Beat
Meet
Miss

Where is TRNX's stock price going from here?
Up
Flat
Down
Stock chart of TRNX
Analysts
Summary of analysts' recommendations for TRNX
Score
Grade
Pivots
Resistance
$3.40
$3.09
$2.59

$2.28

Support
$1.78
$1.47
$0.97
Tweet
Growth
Description
Tornier N.V. operates as a medical device company offering products that treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The Company's products are organized in four major categories: upper extremity joints and trauma, lower extremity joints and trauma, sports medicine and orthobiologics, and large joints and other. The upper extremity products include joint replacement and bone fixation devices for the shoulder, hand, wrist and elbow; lower extremity products include joint replacement and bone fixation devices for the foot and ankle; sports medicine and orthobiologics product category includes products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries; and large joints and other products include hip and knee joint replacement implants and ancillary products. Tornier N.V. is based in Amsterdam, The Netherlands.